GILEAD SCIENCES, INC. Deferred Income Tax Expense (Benefit)
GILEAD SCIENCES, INC. (GILD) reported Deferred Income Tax Expense (Benefit) of -$408.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-06
- GILEAD SCIENCES, INC. deferred income tax expense (benefit) for the quarter ending 2026-06-30 was -$587.00M.
- GILEAD SCIENCES, INC. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was $179.00M.
- GILEAD SCIENCES, INC. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was -$122.00M.
- GILEAD SCIENCES, INC. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $659.00M.
- GILEAD SCIENCES, INC. deferred income tax expense (benefit) for fiscal 2025 was $160.00M.
- GILEAD SCIENCES, INC. deferred income tax expense (benefit) for fiscal 2024 was -$1.84B.
- GILEAD SCIENCES, INC. deferred income tax expense (benefit) for fiscal 2023 was -$962.00M.
- GILEAD SCIENCES, INC. deferred income tax expense (benefit) for fiscal 2022 was -$1.55B.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$587.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$408.00M 10-Q · filed 2026-08-06 | -$530.00M derived: sum of 3 quarters · filed 2026-08-06 | $129.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $179.00M 10-Q · filed 2026-05-07 | $57.00M derived: sum of 2 quarters · filed 2026-05-07 | $716.00M derived: sum of 3 quarters · filed 2026-05-07 | $538.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$122.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $537.00M derived: sum of 2 quarters · filed 2026-02-24 | $359.00M derived: sum of 3 quarters · filed 2026-08-06 | $160.00M 10-K · filed 2026-02-24 |
| 2025-09-30 | $659.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $481.00M derived: sum of 2 quarters · filed 2026-08-06 | $282.00M 10-Q · filed 2025-11-07 | -$97.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$178.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$377.00M 10-Q · filed 2026-08-06 | -$756.00M derived: sum of 3 quarters · filed 2026-08-06 | -$1.33B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$199.00M 10-Q · filed 2026-05-07 | -$578.00M derived: sum of 2 quarters · filed 2026-05-07 | -$1.15B derived: sum of 3 quarters · filed 2026-05-07 | -$1.32B derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$379.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$955.00M derived: sum of 2 quarters · filed 2026-02-24 | -$1.12B derived: sum of 3 quarters · filed 2026-02-24 | -$1.84B 10-K · filed 2026-02-24 |
| 2024-09-30 | -$576.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$742.00M derived: sum of 2 quarters · filed 2025-11-07 | -$1.47B 10-Q · filed 2025-11-07 | -$1.83B derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | -$166.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$889.00M 10-Q · filed 2025-08-07 | -$1.26B derived: sum of 3 quarters · filed 2026-02-24 | -$1.33B derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$723.00M 10-Q · filed 2025-05-07 | -$1.09B derived: sum of 2 quarters · filed 2026-02-24 | -$1.16B derived: sum of 3 quarters · filed 2026-02-24 | -$1.38B derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | -$370.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$438.00M derived: sum of 2 quarters · filed 2026-02-24 | -$659.00M derived: sum of 3 quarters · filed 2026-02-24 | -$962.00M 10-K · filed 2026-02-24 |
| 2023-09-30 | -$68.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$289.00M derived: sum of 2 quarters · filed 2024-11-12 | -$592.00M 10-Q · filed 2024-11-12 | -$930.00M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$221.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$524.00M 10-Q · filed 2024-08-08 | -$862.00M derived: sum of 3 quarters · filed 2025-02-28 | -$1.13B derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$303.00M 10-Q · filed 2024-05-08 | -$641.00M derived: sum of 2 quarters · filed 2025-02-28 | -$911.00M derived: sum of 3 quarters · filed 2025-02-28 | -$1.20B derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$338.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$608.00M derived: sum of 2 quarters · filed 2025-02-28 | -$901.00M derived: sum of 3 quarters · filed 2025-02-28 | -$1.55B 10-K · filed 2025-02-28 |
| 2022-09-30 | -$270.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$563.00M derived: sum of 2 quarters · filed 2023-11-07 | -$1.21B 10-Q · filed 2023-11-07 | -$1.57B derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | -$293.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$944.00M 10-Q · filed 2023-08-04 | -$1.30B derived: sum of 3 quarters · filed 2024-02-23 | -$1.06B derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | -$651.00M 10-Q · filed 2023-05-03 | -$1.01B derived: sum of 2 quarters · filed 2024-02-23 | -$770.00M derived: sum of 3 quarters · filed 2024-02-23 | -$838.00M derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | -$359.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$119.00M derived: sum of 2 quarters · filed 2024-02-23 | -$187.00M derived: sum of 3 quarters · filed 2024-02-23 | -$116.00M 10-K · filed 2024-02-23 |
| 2021-09-30 | $240.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $172.00M derived: sum of 2 quarters · filed 2022-11-02 | $243.00M 10-Q · filed 2022-11-02 | $41.00M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | -$68.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $3.00M 10-Q · filed 2022-08-08 | -$199.00M derived: sum of 3 quarters · filed 2023-02-22 | -$320.00M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $71.00M 10-Q · filed 2022-05-04 | -$131.00M derived: sum of 2 quarters · filed 2023-02-22 | -$252.00M derived: sum of 3 quarters · filed 2023-02-22 | -$199.00M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | -$202.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$323.00M derived: sum of 2 quarters · filed 2023-02-22 | -$270.00M derived: sum of 3 quarters · filed 2023-02-22 | -$214.00M 10-K · filed 2023-02-22 |
| 2020-09-30 | -$121.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$68.00M derived: sum of 2 quarters · filed 2021-11-03 | -$12.00M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $53.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $109.00M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $56.00M 10-Q · filed 2021-05-06 | |||
| 2019-09-30 | -$824.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$820.00M derived: sum of 2 quarters · filed 2020-11-04 | -$796.00M 10-Q · filed 2020-11-04 | |
| 2019-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $28.00M 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $24.00M 10-Q · filed 2020-05-06 | |||
| 2018-09-30 | $12.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$25.00M derived: sum of 2 quarters · filed 2019-11-05 | $10.00M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | -$37.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$2.00M 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $35.00M 10-Q · filed 2019-05-08 | |||
| 2017-09-30 | -$11.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $69.00M derived: sum of 2 quarters · filed 2018-11-06 | $127.00M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $80.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $138.00M 10-Q · filed 2018-08-06 | ||
| 2017-03-31 | $58.00M 10-Q · filed 2018-05-09 | |||
| 2016-09-30 | $21.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$110.00M derived: sum of 2 quarters · filed 2017-11-07 | -$95.00M 10-Q · filed 2017-11-07 | |
| 2016-06-30 | -$131.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$116.00M 10-Q · filed 2017-08-07 | ||
| 2016-03-31 | $15.00M 10-Q · filed 2017-05-10 | |||
| 2011-06-30 | $19.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | $40.01M 10-Q · filed 2011-08-05 | $9.44M derived: sum of 3 quarters · filed 2011-08-05 | $22.26M derived: sum of 4 quarters · filed 2011-08-05 |
| 2011-03-31 | $20.55M 10-Q · filed 2011-05-09 | -$10.02M derived: sum of 2 quarters · filed 2011-05-09 | $2.80M derived: sum of 3 quarters · filed 2011-05-09 | $1.64M derived: sum of 4 quarters · filed 2011-08-05 |
| 2010-12-31 | -$30.57M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | -$17.74M derived: sum of 2 quarters · filed 2011-02-28 | -$18.91M derived: sum of 3 quarters · filed 2011-08-05 | $12.15M 10-K · filed 2011-02-28 |
| 2010-09-30 | $12.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $11.66M derived: sum of 2 quarters · filed 2011-08-05 | $42.72M 10-Q · filed 2010-11-08 | -$10.63M derived: sum of 4 quarters · filed 2011-08-05 |
| 2010-06-30 | -$1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | $29.90M 10-Q · filed 2011-08-05 | -$23.46M derived: sum of 3 quarters · filed 2011-08-05 | -$32.53M derived: sum of 4 quarters · filed 2011-08-05 |
| 2010-03-31 | $31.06M 10-Q · filed 2011-05-09 | -$22.29M derived: sum of 2 quarters · filed 2011-05-09 | -$31.36M derived: sum of 3 quarters · filed 2011-05-09 | -$22.26M derived: sum of 4 quarters · filed 2011-05-09 |
| 2009-12-31 | -$53.35M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | -$62.42M derived: sum of 2 quarters · filed 2011-02-28 | -$53.32M derived: sum of 3 quarters · filed 2011-02-28 | -$42.01M 10-K · filed 2011-02-28 |
| 2009-09-30 | -$9.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $34.00K derived: sum of 2 quarters · filed 2010-11-08 | $11.34M 10-Q · filed 2010-11-08 | -$32.13M derived: sum of 4 quarters · filed 2011-02-28 |
| 2009-06-30 | $9.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | $20.41M 10-Q · filed 2010-08-09 | -$23.06M derived: sum of 3 quarters · filed 2011-02-28 | -$4.40M derived: sum of 4 quarters · filed 2011-02-28 |
| 2009-03-31 | $11.30M 10-Q · filed 2010-05-10 | -$32.16M derived: sum of 2 quarters · filed 2011-02-28 | -$13.51M derived: sum of 3 quarters · filed 2011-02-28 | |
| 2008-12-31 | -$43.47M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | -$24.81M derived: sum of 2 quarters · filed 2011-02-28 | -$24.97M 10-K · filed 2011-02-28 | |
| 2008-09-30 | $18.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $18.50M 10-Q · filed 2009-11-05 | ||
| 2008-06-30 | -$158.00K 10-Q · filed 2009-08-05 | |||
| 2007-12-31 | $113.38M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |